the-103

N/A

Report date: 2025/03/20 09:31:47
NME

Base Information

Drug Namethe-103
Drug Alias Namethe-1 series (Thelial Technologies)
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEosinophilic EsophagitisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThelial Technologies SA
China Registration ClassN/A

Develop Information

Active CompaniesThelial Technologies SA
Inactive CompaniesN/A
Active IndicationsEosinophilic Esophagitis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A